The role of IGF/IGF-1R signaling in the regulation of cancer stem cells
- PMID: 38865036
- DOI: 10.1007/s12094-024-03561-x
The role of IGF/IGF-1R signaling in the regulation of cancer stem cells
Abstract
Cancer stem cells (CSCs) are a group of tumor cells with high tumorigenic ability and self-renewal potential similar to those of normal stem cells. CSCs are the key "seeds" for tumor development, metastasis, and recurrence. A better insight into the key mechanisms underlying CSC survival improves the efficiency of cancer therapy via specific targeting of CSCs. Insulin-like growth factor (IGF)/IGF-1 receptor (IGF-1R) signaling plays an important role in the maintenance of cancer stemness. However, the effect of IGF/IGF-1R signaling on stemness and CSCs and the underlying mechanisms are still controversial. Based on the similarity between CSCs and normal stem cells, this review discusses emerging data on the functions of IGF/IGF-1R signaling in normal stem cells and CSCs and dissects the underlying mechanisms by which IGF/IGF-1R signaling is involved in CSCs. On the other hand, this review highlighted the role of IGF/IGF-1R signaling blockade in multiple CSCs as a potential strategy to improve CSC-based therapy.
Keywords: 1; 1R; 1R signaling; 2; Cancer stem cells; IGF; IGF/IGF; IGFBPs.
© 2024. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).
Conflict of interest statement
Similar articles
-
An active IGF-1R-AKT signaling imparts functional heterogeneity in ovarian CSC population.Sci Rep. 2016 Nov 7;6:36612. doi: 10.1038/srep36612. Sci Rep. 2016. PMID: 27819360 Free PMC article.
-
Targeting cancer stem cell plasticity through modulation of epidermal growth factor and insulin-like growth factor receptor signaling in head and neck squamous cell cancer.Stem Cells Transl Med. 2014 Sep;3(9):1055-65. doi: 10.5966/sctm.2013-0214. Epub 2014 Jul 14. Stem Cells Transl Med. 2014. PMID: 25024430 Free PMC article.
-
The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.Breast Cancer Res. 2013 May 12;15(3):R39. doi: 10.1186/bcr3423. Breast Cancer Res. 2013. PMID: 23663564 Free PMC article.
-
Mini Review: Molecular Interpretation of the IGF/IGF-1R Axis in Cancer Treatment and Stem Cells-Based Therapy in Regenerative Medicine.Int J Mol Sci. 2022 Oct 4;23(19):11781. doi: 10.3390/ijms231911781. Int J Mol Sci. 2022. PMID: 36233084 Free PMC article. Review.
-
The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance.Int J Mol Sci. 2021 Feb 16;22(4):1931. doi: 10.3390/ijms22041931. Int J Mol Sci. 2021. PMID: 33669204 Free PMC article. Review.
Cited by
-
Solute carrier family 2 member 2 (glucose transporter 2): a common factor of hepatocyte and hepatocellular carcinoma differentiation.PLoS One. 2025 Apr 25;20(4):e0321020. doi: 10.1371/journal.pone.0321020. eCollection 2025. PLoS One. 2025. PMID: 40279337 Free PMC article.
-
IGF1/IGF1R signaling promotes the expansion of liver CSCs and serves as a potential therapeutic target in HCC.Discov Oncol. 2025 Jun 11;16(1):1058. doi: 10.1007/s12672-025-02890-9. Discov Oncol. 2025. PMID: 40500564 Free PMC article.
-
Insulin‑like growth factor in cancer: New perspectives (Review).Mol Med Rep. 2025 Aug;32(2):209. doi: 10.3892/mmr.2025.13574. Epub 2025 May 26. Mol Med Rep. 2025. PMID: 40417926 Free PMC article. Review.
-
Advances in the role of the IGF signaling system in myelodysplastic syndromes and acute myeloid leukemia.Front Oncol. 2025 Jun 24;15:1540426. doi: 10.3389/fonc.2025.1540426. eCollection 2025. Front Oncol. 2025. PMID: 40630213 Free PMC article. Review.
References
-
- Saygin C, Matei D, Majeti R, Reizes O, Lathia JD. Targeting cancer stemness in the clinic: from hype to hope. Cell Stem Cell. 2019;24(1):25–40. - PubMed
-
- Nassar D, Blanpain C. Cancer stem cells: basic concepts and therapeutic implications. Annu Rev Pathol. 2016;11:47–76. - PubMed
-
- Batlle E, Clevers H. Cancer stem cells revisited. Nat Med. 2017;23(10):1124–34. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources